Emergent BioSolutions wins $52.7m smallpox vaccine contract
Emergent BioSolutions wins $52.7m smallpox vaccine contract
Emergent BioSolutions wins $52.7m smallpox vaccine contract
Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.